Clovis Oncology Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$0.151

+0 (+0%)

At Close: Apr 19, 2023

Currently predicting for Thu, 18 Apr 2024

CLVS Predictions History

1 year ago
JS predicted that CLVS for 2022-07-05 is going $2.69 (11.62%)

1 year ago
Tom Spence predicted that CLVS for 2022-07-05 is going

Rank:

1 year ago
Pat Okeeffe predicted that CLVS for 2022-06-22 is going

Rank:

1 year ago
JS predicted that CLVS for 2022-06-22 is going $1.73 (13.07%)

1 year ago
Sameer Rehman predicted that CLVS for 2022-06-22 is going

Rank:

2 years ago
JS predicted that CLVS for 2021-05-03 is going $5.90 (2.25%)

2 years ago
jahidjalil89.236181 predicted that CLVS for 2021-05-03 is going $5.94 (2.95%)

Rank:

3 years ago
JS predicted that CLVS for 2021-03-29 is going $6.29 (-0.47%)

3 years ago
BAFAIZ predicted that CLVS for 2021-03-29 is going

Rank:

3 years ago
Max Weber predicted that CLVS for 2021-03-29 is going

Rank:

About Clovis Oncology

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Golden Star

Ticker	Date	Change	Price
ITCI	Apr 05	12.05%	$68.44
AKR	Apr 05	0.665%	$16.53
SARK	Mar 28	16.07%	$26.88
ARCC	Mar 25	1.04%	$20.12
STT	Mar 19	0.262%	$72.62
GGB	Mar 19	0.468%	$4.27
CAG	Mar 18	7.16%	$28.22
JBI	Mar 15	1.29%	$14.72
MASI	Mar 14	3.34%	$132.20
CMC	Mar 14	5.04%	$53.19

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

Clovis Oncology Stock Predictions

CLVS Predictions History

About Clovis Oncology

Golden Star

Top Fintech Company